Cargando…

Assessing the Long-Term Impact of Treating Hepatitis C Virus (HCV)-Infected People Who Inject Drugs in the UK and the Relationship between Treatment Uptake and Efficacy on Future Infections

OBJECTIVE: The prevalence of the hepatitis C virus (HCV) remains high amongst people who inject drugs (PWID) and accounts for the majority of newly acquired infections. This study aims to quantify the value of treatment amongst PWID with more efficacious treatments and at increased uptake rates, wit...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bennett, Hayley, McEwan, Phil, Sugrue, Daniel, Kalsekar, Anupama, Yuan, Yong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4418568/ https://www.ncbi.nlm.nih.gov/pubmed/25938458 http://dx.doi.org/10.1371/journal.pone.0125846

Ejemplares similares

Estimating the Clinical and Economic Benefit Associated with Incremental Improvements in Sustained Virologic Response in Chronic Hepatitis C
por: McEwan, Phil, et al.
Publicado: (2015)

Estimating the cost-effectiveness of daclatasvir + sofosbuvir versus sofosbuvir + ribavirin for patients with genotype 3 hepatitis C virus
por: McEwan, Phil, et al.
Publicado: (2017)

Assessment of Unmet Clinical Need in Type 2 Diabetic Patients on Conventional Therapy in the UK
por: Bennett, Hayley, et al.
Publicado: (2014)

HCV and HIV co-infection among people who inject drugs in Vietnam
por: THINH, Vu Toan, et al.
Publicado: (2020)

Reported Low Uptake of HCV Testing among People Who Inject Drugs in Urban Vietnam
por: Thinh, Vu Toan, et al.
Publicado: (2020)

The signal-to-cutoff ratios to predict HCV infection among people who inject drugs
por: Chen, Bing, et al.
Publicado: (2022)

Hepatitis C virus (HCV) infection and re-infection among HCV- and HIV/HCV-infected injection drug users
por: Conway, B, et al.
Publicado: (2010)

695. Infective endocarditis in people who inject drugs (PWID) at UK Medical Center
por: Cari, Evelyn Villacorta, et al.
Publicado: (2020)

Co-infections and transmission networks of HCV, HIV-1 and HPgV among people who inject drugs
por: Tien Ng, Kim, et al.
Publicado: (2015)

Public Health Considerations among People who Inject Drugs with HIV/HCV Co-Infection: A Review
por: Murdock, Rachel M., et al.
Publicado: (2019)

A CCL5 Haplotype Is Associated with Low Seropositivity Rate of HCV Infection in People Who Inject Drugs
por: Huik, Kristi, et al.
Publicado: (2016)

Confirmation of HCV viremia using HCV RNA and core antigen testing on dried blood spot in HIV infected peoples who inject drugs in Vietnam
por: Nguyen, Truong Tam, et al.
Publicado: (2018)

Burden of Illness in UK Subjects with Reported Respiratory Infections Vaccinated or Unvaccinated against Influenza: A Retrospective Observational Study
por: Pockett, Rhys D., et al.
Publicado: (2015)

Comparison of the Efficacies of Direct-Acting Antiviral Treatment for HCV Infection in People Who Inject Drugs and Non-Drug Users
por: Hsu, Jui-Ting, et al.
Publicado: (2022)

2563. The Impact of HCV Educational Training on HIV Providers’ Attitudes, Knowledge, and Uptake of Treatment Initiation in HCV/HIV Co-infected Patients
por: Lau, Abby A, et al.
Publicado: (2019)

A comparison of two biological markers of recent hepatitis C virus (HCV) infection: implications for the monitoring of interventions and strategies to reduce HCV transmission among people who inject drugs
por: Hope, Vivian D, et al.
Publicado: (2018)

Integrated treatment of hepatitis C virus infection among people who inject drugs: A multicenter randomized controlled trial (INTRO-HCV)
por: Fadnes, Lars T., et al.
Publicado: (2021)

Mobile Technology to Increase HIV/HCV Testing and Overdose Prevention/Response among People Who Inject Drugs
por: Aronson, Ian David, et al.
Publicado: (2017)

Disutility of injectable therapies in obesity and type 2 diabetes mellitus: general population preferences in the UK, Canada, and China
por: McEwan, Phil, et al.
Publicado: (2022)

Serum potassium and clinical outcomes in heart failure patients: results of risk calculations in 21 334 patients in the UK
por: Linde, Cecilia, et al.
Publicado: (2019)

Treatment choice, medication adherence and glycemic efficacy in people with type 2 diabetes: a UK clinical practice database study
por: Gordon, Jason, et al.
Publicado: (2018)

HCV elimination among people who inject drugs. Modelling pre- and post–WHO elimination era
por: Gountas, Ilias, et al.
Publicado: (2018)

Modelling the impact of incarceration and prison‐based hepatitis C virus (HCV) treatment on HCV transmission among people who inject drugs in Scotland
por: Stone, Jack, et al.
Publicado: (2017)

Integrated treatment of hepatitis C virus infection among people who inject drugs: study protocol for a randomised controlled trial (INTRO-HCV)
por: Fadnes, Lars T., et al.
Publicado: (2019)

Modelling the long-term benefits of tolvaptan therapy on renal function decline in autosomal dominant polycystic kidney disease: an exploratory analysis using the ADPKD outcomes model
por: Bennett, Hayley, et al.
Publicado: (2019)

Barriers of linkage to HCV viremia testing among people who inject drugs in Georgia
por: Butsashvili, Maia, et al.
Publicado: (2022)

Molecular and spatial epidemiology of HCV among people who inject drugs in Boston, Massachusetts
por: Stopka, Thomas J., et al.
Publicado: (2022)

Impact of current and scaled‐up levels of hepatitis C prevention and treatment interventions for people who inject drugs in three UK settings—what is required to achieve the WHO's HCV elimination targets?
por: Ward, Zoe, et al.
Publicado: (2018)

Managing HCV infection: present and future
por: Rockstroh, Jürgen K
Publicado: (2014)

Serum potassium as a predictor of adverse clinical outcomes in patients with chronic kidney disease: new risk equations using the UK clinical practice research datalink
por: Furuland, Hans, et al.
Publicado: (2018)

Social determinants of HIV/HCV co-infection: A case study from people who inject drugs in rural Puerto Rico
por: Abadie, Roberto, et al.
Publicado: (2017)

Hepatitis C virus care cascade among people who inject drugs in puerto rico: Minimal HCV treatment and substantial barriers to HCV care
por: Aponte-Meléndez, Yesenia, et al.
Publicado: (2023)

Injection partnership characteristics and HCV status associations with syringe and equipment sharing among people who inject drugs
por: Mackesy-Amiti, Mary Ellen, et al.
Publicado: (2023)

Untreated alcohol use disorder in people who inject drugs (PWID) in France: a major barrier to HCV treatment uptake (the ANRS‐FANTASIO study)
por: Barré, Tangui, et al.
Publicado: (2019)

The Health Economic Value of Changes in Glycaemic Control, Weight and Rates of Hypoglycaemia in Type 1 Diabetes Mellitus
por: McEwan, Phil, et al.
Publicado: (2016)

Eradication of hepatitis C infection: The importance of targeting people who inject drugs
por: Hellard, Margaret, et al.
Publicado: (2014)

Gaps in HCV Knowledge and Risk Behaviors among Young Suburban People Who Inject Drugs
por: Jost, John J., et al.
Publicado: (2019)

Diverse HCV Strains And HIV URFS Identified Amongst People Who Inject Drugs In India
por: Rodgers, Mary A., et al.
Publicado: (2020)

Real-world Efficacy of Direct-Acting Antiviral Therapy for HCV Infection Affecting People Who Inject Drugs Delivered in a Multidisciplinary Setting
por: Alimohammadi, Arshia, et al.
Publicado: (2018)

Baseline prevalence and correlates of HIV and HCV infection among people who inject drugs accessing a syringe services program; Miami, FL
por: Bartholomew, Tyler S., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_sjuv9qlvtfnht7sih5gnut5nfa